Preliminary evaluation of a model of stimulant use, oxidative damage and executive dysfunction

References

• Yamamoto BK, Bankson MG. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit Rev Neurobiol 2005;17:87–117
   PubMedGoogle Scholar
• Poon HF, Abdullah L, Mullan MA, Mullan MJ, Crawford FC. Cocaine-induced oxidative stress precedes cell death in human neuronal progenitor cells. Neurochem Int 2007;50:69–73
   PubMed Web of Science ®Google Scholar
• Cunha-Oliveira T, Rego AC, Oliveira CR. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res Rev 2008;58:192–208
   PubMed Web of Science ®Google Scholar
• Paulus MP, Tapert SF, Schuckit MA. Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry 2005;62:761–768
   PubMed Web of Science ®Google Scholar
• Yuan J, Hatzidimitriou G, Suthar P, Mueller M, McCann U, Ricaurte G. Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys. J Pharmacol Exp Ther 2006;316:1210–1218
   PubMed Web of Science ®Google Scholar
• Yamamoto BK, Moszczynska A, Gudelsky GA. Amphetamine toxicities: classical and emerging mechanisms. In: Uhl GR, ed. Addiction reviews 2. Vol 1187;2010:101–121
   Google Scholar
• Baumann MH, Raley TJ, Partilla JS, Rothman RB. Biosynthesis of dopamine and serotonin in the rat brain after repeated cocaine injections: a microdissection mapping study. Synapse 1993;14:40–50
   PubMed Web of Science ®Google Scholar
• Ersche KD, Jones PS, Williams GB, Robbins TW, Bullmore ET. Cocaine dependence: a fast-track for brain ageing? Mol Psychiatry 2013;18:134--135
   Google Scholar
• Pappas S. Cocaine eats up brain twice as fast as normal aging. Interview with Ersche, 2012. Available at: http://www.foxnews.com/health/2012/04/25/cocaine-eats-up-brain-twice-as-fast-as-normal-aging/ [last accessed 30 October 2012]. (Archived at http://www.webcitation.org/6CIM15ctW on 19 November 2012)
   Google Scholar
• Ancelin ML, Christen Y, Ritchie K. Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence. Dement Geriatr Cogn Disord 2007;24:1–19
   PubMed Web of Science ®Google Scholar
• Berr C. Cognitive impairment and oxidative stress in the elderly: results of epidemiological studies. Biofactors 2000;3:205–209
   Google Scholar
• Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A. Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Arteriel. J Am Geriatr Soc 2000;48:1285–1291
   PubMed Web of Science ®Google Scholar
• Fukui K, Omoi NO, Hayasaka T, Shinnkai T, Suzuki S, Abe K, Urano S. Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Ann NY Acad Sci 2002;959:275–284
   PubMed Web of Science ®Google Scholar
• Serrano F, Klann E. Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res Rev 2004;3:431–443
   PubMed Web of Science ®Google Scholar
• Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET. Abnormal brain structure implicated in stimulant drug addiction. Science 2012;335:601–604
   PubMed Web of Science ®Google Scholar
• Goldstein RZ, Moeller SJ, Volkow ND. Cognitive disruptions in drug addiction: a focus on the prefrontal cortex. In: Adinoff B, Stein EA, eds. Neuroimaging in addiction. Chichester, West Sussex, UK: John Wiley & Sons; 2011:179–210
   Google Scholar
• Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010;35:217–238
   PubMed Web of Science ®Google Scholar
• Verdejo-Garcia A, Benbrook A, Funderburk F, David P, Cadet JL, Bolla KI. The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task. Drug Alcohol Depend 2007;90:2–11
   PubMed Web of Science ®Google Scholar
• Winhusen TM, Somoza EC, Lewis DF, Kropp FB, Horigian VE, Adinoff B. Frontal systems deficits in stimulant-dependent patients: evidence of pre-illness dysfunction and relationship to treatment response. Drug Alcohol Depend 2013;127:94–100
   PubMed Web of Science ®Google Scholar
• Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 2011;12:652–669
   PubMed Web of Science ®Google Scholar
• Jovanovski D, Erb S, Zakzanis KK. Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Exp Neuropsychol 2005;27:189–204
   PubMed Web of Science ®Google Scholar
• Marshall JF, O'Dell SJ. Methamphetamine influences on brain and behavior: unsafe at any speed? Trends Neurosci 2012;35:536–545
   PubMed Web of Science ®Google Scholar
• Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, Cecchetti R, Mecocci P. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res Rev 2009;8:285–305
   PubMed Web of Science ®Google Scholar
• Frenzilli G, Scarcelli V, Fornai F, Paparelli A, Nigro M. The comet assay as a method of assessment of neurotoxicity – usefulness for drugs of abuse. In: Ali S, Fornai FF, eds. Cellular and molecular mechanisms of drugs of abuse and neurotoxicity: cocaine, GHBBH, and substituted amphetamines. Boston: Blackwell Publishing; 2006:478–481
   Google Scholar
• Migliore L, Fontana I, Trippi F, Colognato R, Coppede F, Tognoni G, Nucciarone B, Siciliano G. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging 2005;26:567–573
   PubMed Web of Science ®Google Scholar
• Donovan DM, Daley DC, Brigham GS, Hodgkins CC, Perl HI, Garrett SB, Doyle SR. Stimulant abuser groups to engage in 12-Step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network. J Subst Abuse Treat 2013;44:103–114
   PubMed Web of Science ®Google Scholar
• Hudziak J, Helzer JE, Wetzel MW, Kessel KB, McGee B, Janca A, Przybeck T. The use of the DSM-III-R checklist for initial diagnostic assessments. Compr Psychiatry 1993;34:375–383
   PubMed Web of Science ®Google Scholar
• Le Bihan YV, Izquierdo MA, Coste F, Aller P, Culard F, Gehrke TH, Essalhi K. 5-Hydroxy-5-methylhydantoin DNA lesion, a molecular trap for DNA glycosylases. Nucleic Acids Res 2011;39:6277–6290
   PubMed Web of Science ®Google Scholar
• Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184–191
   PubMed Web of Science ®Google Scholar
• Grace J, Malloy P. Frontal Systems Behavior Scale (FrSBe): professional manual. Lutz (FL): Psychological Assessment Resources; 2001
   Google Scholar
• Malloy P, Grace J. A review of rating scales for measuring behavior change due to frontal systems damage. Cogn Behav Neurol 2005;18:18–27
   PubMed Web of Science ®Google Scholar
• Velligan DI, Ritch JL, Sui D, DiCocco M, Huntzinger CD. Frontal systems behavior scale in schizophrenia: relationships with psychiatric symptomatology, cognition and adaptive function. Psychiatry Res 2002;113:227–236
   PubMed Web of Science ®Google Scholar
• Cahn-Weiner DA, Grace J, Ott BR, Fernandez HH, Friedman JH. Cognitive and behavioral features discriminate between Alzheimer’s and Parkinson’s disease. Neuropsychiatry Neuropsychol Behav Neurol 2002;15:79–87
   PubMedGoogle Scholar
• Chiaravalloti ND, DeLuca J. Assessing the behavioral consequences of multiple sclerosis: an application of the Frontal Systems Behavior Scale (FrSBe). Cogn Behav Neurol 2003;16:54–67
   PubMed Web of Science ®Google Scholar
• Lane-Brown AT, Tate RL. Measuring apathy after traumatic brain injury: psychometric properties of the apathy evaluation scale and the frontal systems behavior scale. Brain Inj 2009;23:999–1007
   PubMed Web of Science ®Google Scholar
• Malloy P, Tremont G, Grace J, Frakey L. The frontal systems behavior scale discriminates frontotemporal dementia from Alzheimer’s disease. Alzheimers Dement 2007;3:200–203
   PubMed Web of Science ®Google Scholar
• Paulsen JS, Stout JC, DelaPena J, Romero R, Tawfik-Reedy Z, Swensen MR, Grace J, et al. Frontal behavioral syndromes in cortical and subcortical dementia. Assessment 1996;3:327–337
   Google Scholar
• Fals-Stewart W, O’Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 2000;68:134–144
   PubMed Web of Science ®Google Scholar
• Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173–1182
   PubMed Web of Science ®Google Scholar
• MacKinnon DP, Dwyer JH. Estimating mediated effects in prevention studies. Eval Rev 1993;17:144–158
   Web of Science ®Google Scholar
• Herr NR. Mediation with dichotomous outcomes. 2011; Available at: http://www.nrhpsych.com/mediation/logmed.html
   Google Scholar
• Kenny DA. Mediation. 25 September 2011; Available at: http://davidakenny.net/cm/mediate.htm
   Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988
   Google Scholar
• Nakagawa S. A farewell to Bonferroni: the problems of low statistical power and publication bias. Behav Ecol 2004;15:1044–1045
   Web of Science ®Google Scholar
• Verdejo-Garcia A, Perez-Garcia M. Substance abusers’ self-awareness of the neurobehavioral consequences of addiction. Psychiatry Res 2008;158:172–180
   PubMed Web of Science ®Google Scholar
• Moeller SJ, Maloney T, Parvaz MA, Alia-Klein N, Woicik PA, Telang F, Wang GJ, et al. Impaired insight in cocaine addiction: laboratory evidence and effects on cocaine-seeking behaviour. Brain 2010;133:1484–1493
   PubMed Web of Science ®Google Scholar